ESR1 and thyroid gland carcinoma: The researchers showed that a vitamin D analog JK 1624 F2-2 could modulate not only the VDR receptor and 1,25(OH)2D3 but also the ER, which is implicated in estrogen-induced cell proliferation in thyroid cancer cell lines in an ER-type specific way [77].